Marco Filetti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Precision medicine: Beyond AI	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE UPDATE	2024
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer	JOURNAL OF CLINICAL ONCOLOGY	2023
Efficacy and safety of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis	CANCER TREATMENT REVIEWS	2023
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients	CURRENT ONCOLOGY	2023
Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings	CANCERS	2023
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer	CLINICAL CANCER RESEARCH	2023
Palliative sedation and time to death in home palliative care: retrospective analysis	BMJ SUPPORTIVE & PALLIATIVE CARE	2023
La medicina di precisione come opera d’arte collettiva	RECENTI PROGRESSI IN MEDICINA	2023
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status	JOURNAL OF HEMATOLOGY & ONCOLOGY	2022
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years	CANCERS	2022
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario	ESMO OPEN	2022
EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature	TRANSLATIONAL LUNG CANCER RESEARCH	2022
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis	CANCER TREATMENT REVIEWS	2022
Patients' Satisfaction with Breakthrough Cancer Pain Therapy. A Secondary Analysis of IOPS-MS Study	CANCER MANAGEMENT AND RESEARCH	2022
[Medical cannabis. Facilitate the proposal and sustainability for the training of healthcare personnel and the conduct of clinical trials in the cancer population.]	RECENTI PROGRESSI IN MEDICINA	2022
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer	EUROPEAN JOURNAL OF CANCER	2022
DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients	ANNALS OF ONCOLOGY	2022
New driver alterations in non-small cell lung cancer: A narrative review	PRECISION CANCER MEDICINE	2022
133P ARID1A-mutated cancers: New prospectives for treatment of a subgroup of gynecological cancer	ANNALS OF ONCOLOGY	2022
1576P Efficacy of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A network meta-analysis	ANNALS OF ONCOLOGY	2022

Progetti di Ricerca

Evaluation of MYC expression as a predictor of response to chemo-immunotherapy treatment in small cell lung cancer.
Circulating pro inflammatory cytokines levels as a prognostic role in immunotherapy DLT and survival in Stage IV NSCLC patients undergone 1st and 2nd line Immunotherapy.
Double Trouble. Impact of a double EGFR mutation in clinical outcomes for first line therapy in advanced NSCLC.